ERO COPPER CORP (ERO) Fundamental Analysis & Valuation

NYSE:ERO • CA2960061091

Current stock price

28.1 USD
+0.05 (+0.18%)
At close:
28.4915 USD
+0.39 (+1.39%)
After Hours:

This ERO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ERO Profitability Analysis

1.1 Basic Checks

  • ERO had positive earnings in the past year.
  • In the past year ERO had a positive cash flow from operations.
  • Of the past 5 years ERO 4 years were profitable.
  • ERO had a positive operating cash flow in each of the past 5 years.
ERO Yearly Net Income VS EBIT VS OCF VS FCFERO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • ERO has a better Return On Assets (13.71%) than 91.14% of its industry peers.
  • Looking at the Return On Equity, with a value of 28.19%, ERO belongs to the top of the industry, outperforming 92.41% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 13.17%, ERO belongs to the top of the industry, outperforming 84.81% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ERO is significantly below the industry average of 61.56%.
  • The 3 year average ROIC (8.91%) for ERO is below the current ROIC(13.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.71%
ROE 28.19%
ROIC 13.17%
ROA(3y)5.05%
ROA(5y)10.57%
ROE(3y)9.36%
ROE(5y)19.62%
ROIC(3y)8.91%
ROIC(5y)15.07%
ERO Yearly ROA, ROE, ROICERO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

1.3 Margins

  • ERO has a Profit Margin of 33.56%. This is amongst the best in the industry. ERO outperforms 91.77% of its industry peers.
  • ERO's Profit Margin has improved in the last couple of years.
  • The Operating Margin of ERO (34.57%) is better than 80.38% of its industry peers.
  • ERO's Operating Margin has declined in the last couple of years.
  • ERO has a better Gross Margin (43.99%) than 75.32% of its industry peers.
  • In the last couple of years the Gross Margin of ERO has declined.
Industry RankSector Rank
OM 34.57%
PM (TTM) 33.56%
GM 43.99%
OM growth 3Y4.33%
OM growth 5Y-5.81%
PM growth 3Y12.01%
PM growth 5Y16.08%
GM growth 3Y0.07%
GM growth 5Y-5.39%
ERO Yearly Profit, Operating, Gross MarginsERO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ERO Health Analysis

2.1 Basic Checks

  • ERO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • ERO has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ERO has more shares outstanding
  • ERO has a better debt/assets ratio than last year.
ERO Yearly Shares OutstandingERO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ERO Yearly Total Debt VS Total AssetsERO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • ERO has an Altman-Z score of 3.20. This indicates that ERO is financially healthy and has little risk of bankruptcy at the moment.
  • ERO has a Altman-Z score (3.20) which is in line with its industry peers.
  • The Debt to FCF ratio of ERO is 5.61, which is a neutral value as it means it would take ERO, 5.61 years of fcf income to pay off all of its debts.
  • ERO has a Debt to FCF ratio of 5.61. This is in the better half of the industry: ERO outperforms 68.99% of its industry peers.
  • ERO has a Debt/Equity ratio of 0.60. This is a neutral value indicating ERO is somewhat dependend on debt financing.
  • ERO has a worse Debt to Equity ratio (0.60) than 74.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 5.61
Altman-Z 3.2
ROIC/WACC1.08
WACC12.21%
ERO Yearly LT Debt VS Equity VS FCFERO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that ERO should not have too much problems paying its short term obligations.
  • ERO's Current ratio of 1.06 is on the low side compared to the rest of the industry. ERO is outperformed by 82.91% of its industry peers.
  • A Quick Ratio of 0.63 indicates that ERO may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.63, ERO is doing worse than 83.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.63
ERO Yearly Current Assets VS Current LiabilitesERO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ERO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 171.79% over the past year.
  • ERO shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.14% yearly.
  • The Revenue has grown by 67.11% in the past year. This is a very strong growth!
  • Measured over the past years, ERO shows a quite strong growth in Revenue. The Revenue has been growing by 19.38% on average per year.
EPS 1Y (TTM)171.79%
EPS 3Y32.57%
EPS 5Y11.14%
EPS Q2Q%511.76%
Revenue 1Y (TTM)67.11%
Revenue growth 3Y22.61%
Revenue growth 5Y19.38%
Sales Q2Q%161.35%

3.2 Future

  • Based on estimates for the next years, ERO will show a decrease in Earnings Per Share. The EPS will decrease by -1.37% on average per year.
  • The Revenue is expected to grow by 4.45% on average over the next years.
EPS Next Y92.19%
EPS Next 2Y42.52%
EPS Next 3Y17.17%
EPS Next 5Y-1.37%
Revenue Next Year54.77%
Revenue Next 2Y24.41%
Revenue Next 3Y10.21%
Revenue Next 5Y4.45%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ERO Yearly Revenue VS EstimatesERO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
ERO Yearly EPS VS EstimatesERO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

8

4. ERO Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.25, the valuation of ERO can be described as correct.
  • ERO's Price/Earnings ratio is rather cheap when compared to the industry. ERO is cheaper than 91.77% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ERO to the average of the S&P500 Index (25.60), we can say ERO is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 6.90 indicates a rather cheap valuation of ERO.
  • 91.77% of the companies in the same industry are more expensive than ERO, based on the Price/Forward Earnings ratio.
  • ERO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.84.
Industry RankSector Rank
PE 13.25
Fwd PE 6.9
ERO Price Earnings VS Forward Price EarningsERO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ERO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ERO is cheaper than 83.54% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ERO is valued cheaply inside the industry as 81.65% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 25.98
EV/EBITDA 8.9
ERO Per share dataERO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • ERO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ERO has a very decent profitability rating, which may justify a higher PE ratio.
  • ERO's earnings are expected to grow with 17.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.14
PEG (5Y)1.19
EPS Next 2Y42.52%
EPS Next 3Y17.17%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ERO Dividend Analysis

5.1 Amount

  • ERO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ERO Fundamentals: All Metrics, Ratios and Statistics

ERO COPPER CORP

NYSE:ERO (4/2/2026, 8:21:22 PM)

After market: 28.4915 +0.39 (+1.39%)

28.1

+0.05 (+0.18%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-05
Earnings (Next)05-04
Inst Owners73.07%
Inst Owner Change-2.49%
Ins Owners5.86%
Ins Owner ChangeN/A
Market Cap2.93B
Revenue(TTM)785.84M
Net Income(TTM)263.72M
Analysts74
Price Target34.72 (23.56%)
Short Float %3.26%
Short Ratio1.76
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-22.39%
Min EPS beat(2)-43.87%
Max EPS beat(2)-0.91%
EPS beat(4)2
Avg EPS beat(4)10.68%
Min EPS beat(4)-43.87%
Max EPS beat(4)76.3%
EPS beat(8)4
Avg EPS beat(8)5.58%
EPS beat(12)5
Avg EPS beat(12)2.04%
EPS beat(16)5
Avg EPS beat(16)-8.27%
Revenue beat(2)1
Avg Revenue beat(2)-4.91%
Min Revenue beat(2)-19.98%
Max Revenue beat(2)10.15%
Revenue beat(4)1
Avg Revenue beat(4)-5%
Min Revenue beat(4)-19.98%
Max Revenue beat(4)10.15%
Revenue beat(8)2
Avg Revenue beat(8)-7.05%
Revenue beat(12)3
Avg Revenue beat(12)-6.38%
Revenue beat(16)4
Avg Revenue beat(16)-7.04%
PT rev (1m)0%
PT rev (3m)24.95%
EPS NQ rev (1m)-17.37%
EPS NQ rev (3m)-9.86%
EPS NY rev (1m)5.44%
EPS NY rev (3m)6.23%
Revenue NQ rev (1m)-9.89%
Revenue NQ rev (3m)14.32%
Revenue NY rev (1m)2.99%
Revenue NY rev (3m)5.41%
Valuation
Industry RankSector Rank
PE 13.25
Fwd PE 6.9
P/S 3.73
P/FCF 25.98
P/OCF 7.41
P/B 3.13
P/tB 3.13
EV/EBITDA 8.9
EPS(TTM)2.12
EY7.54%
EPS(NY)4.07
Fwd EY14.5%
FCF(TTM)1.08
FCFY3.85%
OCF(TTM)3.79
OCFY13.5%
SpS7.54
BVpS8.98
TBVpS8.98
PEG (NY)0.14
PEG (5Y)1.19
Graham Number20.7
Profitability
Industry RankSector Rank
ROA 13.71%
ROE 28.19%
ROCE 16.33%
ROIC 13.17%
ROICexc 14.06%
ROICexgc 14.06%
OM 34.57%
PM (TTM) 33.56%
GM 43.99%
FCFM 14.34%
ROA(3y)5.05%
ROA(5y)10.57%
ROE(3y)9.36%
ROE(5y)19.62%
ROIC(3y)8.91%
ROIC(5y)15.07%
ROICexc(3y)9.49%
ROICexc(5y)18.57%
ROICexgc(3y)9.49%
ROICexgc(5y)18.57%
ROCE(3y)11.05%
ROCE(5y)18.68%
ROICexgc growth 3Y-0.12%
ROICexgc growth 5Y-16.92%
ROICexc growth 3Y-0.12%
ROICexc growth 5Y-16.92%
OM growth 3Y4.33%
OM growth 5Y-5.81%
PM growth 3Y12.01%
PM growth 5Y16.08%
GM growth 3Y0.07%
GM growth 5Y-5.39%
F-Score8
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 5.61
Debt/EBITDA 1.45
Cap/Depr 244.1%
Cap/Sales 35.94%
Interest Coverage 6.36
Cash Conversion 102%
Profit Quality 42.73%
Current Ratio 1.06
Quick Ratio 0.63
Altman-Z 3.2
F-Score8
WACC12.21%
ROIC/WACC1.08
Cap/Depr(3y)395.05%
Cap/Depr(5y)414.26%
Cap/Sales(3y)71.83%
Cap/Sales(5y)64.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)171.79%
EPS 3Y32.57%
EPS 5Y11.14%
EPS Q2Q%511.76%
EPS Next Y92.19%
EPS Next 2Y42.52%
EPS Next 3Y17.17%
EPS Next 5Y-1.37%
Revenue 1Y (TTM)67.11%
Revenue growth 3Y22.61%
Revenue growth 5Y19.38%
Sales Q2Q%161.35%
Revenue Next Year54.77%
Revenue Next 2Y24.41%
Revenue Next 3Y10.21%
Revenue Next 5Y4.45%
EBIT growth 1Y124.57%
EBIT growth 3Y27.92%
EBIT growth 5Y12.45%
EBIT Next Year155.58%
EBIT Next 3Y29.39%
EBIT Next 5Y13.82%
FCF growth 1Y158.65%
FCF growth 3YN/A
FCF growth 5Y20.15%
OCF growth 1Y171.72%
OCF growth 3Y40.2%
OCF growth 5Y19.4%

ERO COPPER CORP / ERO Fundamental Analysis FAQ

What is the fundamental rating for ERO stock?

ChartMill assigns a fundamental rating of 5 / 10 to ERO.


What is the valuation status of ERO COPPER CORP (ERO) stock?

ChartMill assigns a valuation rating of 8 / 10 to ERO COPPER CORP (ERO). This can be considered as Undervalued.


Can you provide the profitability details for ERO COPPER CORP?

ERO COPPER CORP (ERO) has a profitability rating of 7 / 10.


What is the financial health of ERO COPPER CORP (ERO) stock?

The financial health rating of ERO COPPER CORP (ERO) is 4 / 10.